glp-1 medications results timeline What are GLP-1s? The transformative breakthroughs in GLP-1

SlateRxs clinical team monitors the evolving pipeline, and our Pharmacy and Therapeutics (P&T) committee evaluates new therapies to guide formulary placement and utilization strategies

26 State Medicaid agencies are able to participate in the model beginning May 2026 and Part D plans in January 2027

Semaglutide remains an excellent choice for many patients who prefer gradual progress or who respond well to GLP-1 therapy

Who qualifies for GLP-1 weight loss treatment

In 1980 Jean-Pierre Raufman, a young gastroenterologist (figure 33), and John Pisano, a biochemist at the National Institute of Health with a fascination for venoms, began investigating the effect of peptides found in the saliva of the lizard on human physiology

It passes through the stomach and small intestine undigested, reaching the colon where beneficial gut bacteria ferment it into short-chain fatty acids - primarily propionate and butyrate